MICHAEL OROS: Open Payments
NPI 1720278914 · NORTH CANTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,986 in 112 payments from 15 companies in 2025. Trend: 2023 $1,858 · 2024 $1,759 · 2025 $1,986
Food & beverage: $1,986
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 24 | $521 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $214 |
| Indivior Inc. | 18 | $196 |
| Janssen Pharmaceuticals, Inc | 10 | $188 |
| Lundbeck LLC | 8 | $160 |
| Axsome Therapeutics, Inc. | 7 | $148 |
| Bausch Health US, LLC | 7 | $115 |
| Neurocrine BioSciences, Inc. | 6 | $110 |
| Almatica Pharma LLC | 6 | $107 |
| Otsuka America Pharmaceutical, Inc. | 3 | $58 |
Products named: HETLIOZ, REXULTI, TRINTELLIX, SUBLOCADE, SPRAVATO, Auvelity, APLENZIN, INGREZZA.
Industry payments across OH — which companies pay providers there.
